Celestial Labs is a combination of a technology and a pharmaceutical company. They have bioinformatics, enterprise resource planning (ERP) and molecule development software for the pharma companies. They are also into herbal and allopathic products. So it's a combination of these two.
We expect earnings per share (EPS) of around Rs 10 for this year. Next year it could be Rs 13-14. These are companies, which are trying to put their act in place. That's the biggest risk.
We could see levels of around Rs 60-70 but at least a short to medium-term target is around Rs 40-45.
Posts
![[ Registered ]](http://www.diarist.net/registry/button.gif){kind=small}
No comments:
Post a Comment